my account
log out
|
|
my account
log out
|
Afuco™ Anti-Human ACVRL1 ADCC Theraputic Antibody (PF-03446962), ADCC Enhanced |
| Create: 07/26/2019 |
| Expired Date: | never |
| Category: | Drugs&Pharmaceutical [Health&Medical&Pharmaceutical] |
| Message: | Anti-ACVRL1 ADCC Enhanced Antibody (PF-03446962) is an ADCC enhanced antibody produced by our Afuco™ platform. PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trial. https://www.creativebiolabs.net/Anti-ACVRL1-ADCC-Enhanced-Antibody-PF-03446962-20318.htm |
 | |
| City: | Shirley[US]
 |
| Location: |
|
| Feb 01 2023 | VBS++ (with Ca and Mg) Buffer | 233 | |
| Feb 01 2023 | GVBE Buffer | 234 | |
| Feb 01 2023 | GVB++ (with Ca and Mg) Buffer | 240 | |
| Feb 01 2023 | Hemolysin (Rabbit Anti-Sheep Cell Hemolysin) | 228 | |
| Aug 30 2019 |  | Anti-HSV-2 gH Antibody | 421 |
| Aug 30 2019 | | Anti-L. major LPG Antibody | 503 |
| Aug 30 2019 | | Anti-DENV-1 Antibody | 413 |
| Aug 30 2019 | | Anti-BPV-1 L1 Antibody | 429 |
| Aug 30 2019 | | Anti-H3N2 HA Antibody | 410 |
| Aug 30 2019 | | Anti-EIAV env Antibody | 438 |
| Copyright © toextrade Inc. All rights reserved. Contact us |